Newsroom

Large industrial fermentation plant made of stainless steel with multiple reactors

News

Phyton Biotech has successfully transferred the manufacturing process for the microbial production of Corallopyronin A (CorA). CorA is a novel anti-infective agent with the potential to address neglected tropical diseases. This achievement marks a signiﬁcant step forward in the Company’s specialty GMP fermentation capabilities and supports the broader clinical development program led by the University Hospital Bonn (UKB), the Helmholtz Centre for Infection Research (HZI) and the German Center for Infection Research (DZIF).

06.02.2026

HZI Campus

HIPS

Two people in lab coats talking in front of a laboratory device

News

On February 5, 2026, the President of the Helmholtz Association, Prof. Martin Keller, visited the Helmholtz Centre for Infection Research (HZI) in Braunschweig. In an open and cordial atmosphere, Keller took part in a comprehensive program that offered insights into the center's current research work, infrastructure and future prospects. Keller, who has been President of the Helmholtz Association since November 1, 2025, placed particular emphasis on direct interaction with HZI employees.

05.02.2026

HZI Campus

Model of a coronavirus captured by a lasso

News

The German National Cohort (NAKO) contributes its scientific expertise to the National Decade of Post-Infectious Diseases initiated by the Federal Ministry of Research, Technology and Space (BMFTR). With two central projects, it makes an important contribution to research into the long-term health consequences of infectious diseases such as Long COVID. The aim of the research decade is to better understand the causes and mechanisms of post-infectious diseases and to develop new treatment options. The Helmholtz Centre for Infection Research (HZI) coordinates the Clinical Research Center (CRC) of the NAKO in Hanover.

02.02.2026

HZI Campus

CRC

News

With funding from the Lower Saxony Ministry of Science and Culture (MWK) and the Volkswagen Foundation, the Helmholtz Centre for Infection Research (HZI) in Braunschweig has launched the large-scale project HUMAN. Interdisciplinary teams are investigating the interactions between humans, bacteria and viruses. Six internationally recruited young researchers are currently setting up new research groups with innovative approaches and bringing cutting-edge research from Stanford, Stockholm and Vienna, among others, to Lower Saxony. The project, led by Prof. Josef Penninger, Scientific Director of the HZI, initially has around 32 million euros available in the program “zukunft.niedersachsen”, with the option of an increase to up to 70 million euros after a successful interim evaluation. Today, the established groups were presented to Lower Saxony's Minister of Science, Falko Mohrs, and the CEO of the Volkswagen Foundation, Dr. Georg Schütte.

02.02.2026

HZI Campus

Illustration of cells with transparent membranes and structures inside the cells

News

How Long COVID develops is still largely unknown. New molecular connections are revealed in a recent study led by the Centre for Individualised Infection Medicine (CiiM). Using their approach of examining different molecular levels within individual cells, the researchers identified a specific condition in immune cells that was directly associated with elevated inflammation markers, fatigue, and respiratory problems in patients with Long COVID. The study was published in the journal Nature Immunology. The CiiM is a joint institution of the Helmholtz Centre for Infection Research (HZI) and Hannover Medical School (MHH).

29.01.2026

CiiM

Futuristic stock photo: Doctor pressing AI button

News

The Helmholtz Association is kicking off 2026 with new research initiatives on strategic future topics to bring technological breakthroughs into practical application more quickly. The Helmholtz initiatives “Biomedical Engineering Initiative,” “Water Safety and Security Initiative,” and “Quantum Use Challenge” are generating innovative solutions – from needle-free blood glucose measurement via wearables to quantum sensors for more powerful batteries and innovative concepts for water management in large cities. The initiatives are being developed in close cooperation with partners from politics, business, and society and address key technologies and strategic research areas of the German government’s High-Tech Agenda. Four projects of the Helmholtz Centre for Infection Research (HZI) and its sites in Greifswald, Saarbrücken and Würzburg are part of the new research campaigns.

22.01.2026

HZI Campus

HIPS

HIRI

HIOH

Back to the first page
...
11
12
13
14
...
162

HZI in the media

... die klinische Validität. Ein Forschungsteam des Helmholtz-Zentrums für Infektionsforschung (HZI) hat mit „Metax“ nun einen ...

02.10.2026

Analytik.de

Mikrobiologen auch Kolleg*innen vom IST Austria und dem HZI in Braunschweig gehören: Inhibitoren von Aktin unterbinden diese dynamischen

01.10.2026

Science.apa.at

... der Medizinischen Hochschule Hannover sowie am Helmholtz-Zentrum für Infektionsforschung tätig ist. Als Co-Autor ist zudem ...

30.09.2026

Ad Hoc News

also included Japanese microbiologists and collaborators from IST Austria and HZI Braunschweig (Germany), demonstrated that actin inhibitors

30.09.2026

Phys.org

for cell movement. Scientists from the Helmholtz Center for Infection Research (HZI) in Braunschweig have provided evidence that Profilin

29.09.2026

TakeToNews

Biology (BRICS), a joint research center of the Helmholtz Centre for Infection Research (HZI) and Technische Universität Braunschweig.

29.09.2026

Phys.org

... treffsicher .

Das Helmholtz-Zentrum für Infektionsforschung:

Wissenschaftler:innen am Helmholtz-Zentrum für Infektionsforschung (HZI) ...

28.09.2026

DeutschesGesundheitsPortal

... Fluorchinolon-Resistenz aktiv

Forscher des Helmholtz-Zentrums für Infektionsforschung (HZI) um Dr. Jennifer Herrmann haben ...

27.09.2026

scinexx - Das Wissensmagazin

Die WHO nennt Antibiotikaresistenzen (AMR) eine der größten globalen Gesundheitsbedrohungen. Bereits heute töten resistente Keime jährlich mehr als eine Million Menschen direkt und tragen zu fast fünf Millionen Todesfällen bei. Tendenz: steigend. Für ein wirkungsvolles Dagegenha

25.09.2026

Sysmex

... die Resistenzen": HZI-Podcast InFact mit Mark Brönstrup

Quelle: Helmholtz-Zentrum für Infektionsforschung (HZI)

Biodiversität ...

25.09.2026

Analytik NEWS

Quelle: Pressemitteilung

Helmholtz-Zentrum für Infektionsforschung

24.09.2026

LaborPraxis

Lange galt Dopamin als simples Glückshormon. Alena Buyx zeigt in ihrer Sendung, dass der Botenstoff ...

24.09.2026

3sat

Register now for the HZI newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.